YOLFTbeta
SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD.

1271 · TWO · Consumer Defensive / Packaged Foods

59.00TWD+0.80 (+1.37%)

Price History

Full chart

Market Stats

Previous Close58.20
Open58.80
Day Range58.10 – 59.00
52-Week Range50.32 – 71.93
Volume25.21K
Market Cap3.59B
P/E (TTM)26.30
Forward P/E0.00
EPS2.27
Dividend Yield1.31%
Beta-0.22
50-Day Avg59.63
200-Day Avg59.70

About

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Pei-Chi Chen
  • HeadquartersNo. 139, Xing ai Road, Taipei, Taiwan, 11494, Taiwan
  • Websitehttps://sunway.cc

Leadership

  • Mr. Pei-Chi ChenChief Executive Officer · b. 1967
  • Mr. Jia-Yue PanVice Chairman & President
  • Brett KoChief Financial Officer
  • Yuanchang ZhengAccounting Supervisor
  • Prof. Tzu-Ming PanChief Technology Officer
  • Jenny SungConsumer Healthcare Head

Financials

Income Statement

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue20.64M13.23M40.52M74.19M71.39M108.65M172.19M314.48M380.43M425.35M571.11M970.18M993.30M
Growth (%)--35.91%+206.37%+83.09%-3.78%+52.19%+58.48%+82.64%+20.97%+11.81%+34.27%+69.88%+2.38%
Cost of Revenue21.41M11.41M34.66M47.84M46.67M58.49M63.51M106.02M109.32M275.46M334.20M425.14M432.80M
Gross Profit-771.00K1.81M5.86M26.36M24.73M50.16M108.68M208.46M271.11M149.89M236.91M545.04M560.50M
Gross Margin-3.74%13.70%14.46%35.52%34.63%46.17%63.12%66.29%71.26%35.24%41.48%56.18%56.43%
Operating Expense69.52M68.38M68.37M84.37M82.35M70.22M66.59M82.57M103.37M110.66M184.47M404.06M456.37M
Operating Income-70.29M-66.57M-62.51M-58.01M-57.63M-20.05M42.09M125.89M167.74M39.23M52.44M140.98M104.13M
Operating Margin-340.60%-503.30%-154.26%-78.19%-80.72%-18.46%24.45%40.03%44.09%9.22%9.18%14.53%10.48%
EBITDA-59.76M-54.26M-46.22M-40.77M-42.93M-7.04M61.93M146.23M190.47M48.54M83.47M231.26M197.44M
EBITDA Margin-289.54%-410.21%-114.06%-54.96%-60.13%-6.48%35.97%46.50%50.07%11.41%14.61%23.84%19.88%
Net Income-70.99M-66.84M-62.14M-62.20M-68.77M-13.53M38.24M125.71M168.76M30.04M46.09M118.57M101.50M
Net Income Margin-343.99%-505.34%-153.35%-83.83%-96.33%-12.45%22.21%39.98%44.36%7.06%8.07%12.22%10.22%
R&D31.63M30.37M24.71M26.80M37.21M29.90M-32.99M43.38M43.78M6.21M54.02M43.53M
R&D as % of Total Revenue153.25%229.62%60.98%36.12%52.12%27.52%-10.49%11.40%10.29%1.09%5.57%4.38%
Interest Expense--19.00K27.00K683.00K764.00K638.00K195.00K90.00K1.15M2.09M5.54M11.26M
Interest Expense % of Total Revenue--0.05%0.04%0.96%0.70%0.37%0.06%0.02%0.27%0.37%0.57%1.13%

Balance Sheet

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets------317.38M511.15M607.70M478.23M3.66B3.79B4.46B
Total Liabilities------38.58M46.53M60.65M190.14M455.11M527.13M1.20B
Total Equity------278.80M462.19M543.66M288.09M3.20B3.26B3.26B
Cash------65.35M295.34M346.44M123.57M362.19M293.70M301.02M
Total Debt------19.68M16.95M20.69M71.34M303.55M249.85M-
Net Debt-------45.66M-278.39M-325.75M-52.23M-58.64M-43.85M358.27M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-181.86M160.76M42.58M55.98M156.92M222.89M
Investing Cash Flow--2.21M-10.86M-3.48M218.78M-125.80M-
Financing Cash Flow-50.31M-98.40M-5.33M-35.46M-99.80M-
Capital Expenditure01.71M9.80M2.59M46.24M123.68M104.02M
Free Cash Flow-180.16M150.96M39.99M9.75M33.24M118.87M
Dividends Paid--92.72M6.43M42.65M59.39M80.32M
FCF to OCF-99.06%93.91%93.92%17.41%21.18%53.33%
Dividend Paid to FCF--61.42%16.09%437.65%178.66%67.57%

Key Statistics & Ratios

Market Cap3.59B
Enterprise Value4.41B
Trailing P/E26.30
Forward P/E0.00
Price / Sales2.34
Price / Book0.84
EPS2.27
Book Value54.32
Revenue (TTM)1.54B
Gross Profit (TTM)719.69M
EBITDA154.73M
Profit Margin8.90%
Operating Margin5.01%
Return on Equity3.69%
Return on Assets1.09%
Shares Outstanding60.09M
Shares Float45.15M
Beta-0.22
Dividend Yield1.31%
Dividend Rate0.78
Payout Ratio58.62%

Dividends

20261×
0.78Jul 30, 2026
20251×
1.33Jul 16, 2025
20241×
0.98Apr 11, 2024
20231×
3.15Mar 23, 2023
20221×
4.23Jun 17, 2022
20211×
2.75Jul 28, 2021

Stock Splits

  • Dec 9, 20241016.8381:1000